Mergers, Acquisitions, Limitless Possibilities.
We're eager to hear from you! If we align with your goals and business needs, our team will take care of everything and connect with you - wherever you may be.
Pharmaceutical Manufacturing Plant in Lappeenranta, Finland for Sale. Now for sale or joint venture – Fully equipped pharma production site in Rauha, South of Karelia, Finland. Offered at just over 5 million euros (incl. P&P and Staff accommodation), this package represents one of the few occasions when these rare components can be combined to provide not just a straightforward regulated business but one clear of encumbrance and with far more infrastructure than is normal for the level of income produced.
The plant, founded in 2012, is EU GMP (Good Manufacturing Practice) certified – a commitment to quality across the complete production process. It specializes in non-sterile pharmaceuticals, such as capsules and powders, and also produces food and feed additives, vitamins, and cosmetics, thus promising a wide range of production possibilities. Planned across two storeys with a total floor area of 3,428 m², the facility is located in a secure 2.12-hectare leased site that is isolated from residential areas and well-suited for pharmaceutical production.
Together, these facilities comprise 36,898 square feet of operational area, transforming the location from a mere plant to a complete production ecosystem.
The company continues to achieve solid cash flow of €250K–€500K and sales of €1M–€5M annually. Currently, the entire product line is exported to both Russia and Kazakhstan. Since the facility lacks EU sales authorizations today, this could be a significant upside for investors looking to tap into regulated European markets. The site also has a vacant GMP-compliant Clean Room and a second raw space for expansion and buildout to accommodate new product lines or contract manufacturing businesses.
The current owner is constructing a bigger facility closer to its core markets, which is the reason for this sale. They are happy for tier two manufacturers seeking contract manufacturing or joint ventures in pharmaceutical manufacturing to contact them. Better yet, they will finance and support a smooth transition into the business. This includes:
Positioned within the Lappeenranta region, the plant enjoys Finland’s extensive pharmaceutical infrastructure, political stability, and strategic location, which is easily accessible to both Eastern and Western markets. Known for its environmental safety and operational compliance, the region is a land of industrial investment.
Once established, the present operations specialize in Eastern European exports, but the plant infrastructure is in place for EU-wide growth. Once the requisite permissions are in hand, this plant could be a linchpin for European distribution, effectively making it a strategic base within the continent for a tightly regulated healthcare industry.
It’s not just a chance to own a building; it’s the chance to slide right into a turn-key, GMP certified Rx operation complete with staff (28 employees), revenue lines, and expansion-ready infrastructure. If you are interested in expanding your pharmaceutical portfolio, broadening your manufacturing capabilities, or growing your business in the European pharmaceutical market with minimal time to set up new operations, this facility offers unparalleled access to both readiness and scale.
Due to the strategic significance and operational readiness of this site, interested parties are invited to contact the seller for comprehensive details, documentation, and financials. This makes it one of the only pharmaceutical plants for sale in Finland that can supply your company with this blend of state-of-the-art quality compliance, infrastructure, and growth capacity; a truly unique acquisition in today’s competitive life sciences market.
Please use the form below to request more information on this business opportunity.
